Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Change in Inventory: 2012-2024

Historic Change in Inventory for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Dec 2024 value amounting to $48.8 million.

  • Amphastar Pharmaceuticals' Change in Inventory fell 180.18% to -$5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.5 million, marking a year-over-year increase of 179.46%. This contributed to the annual value of $48.8 million for FY2024, which is 2730.45% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Change in Inventory stood at $48.8 million for FY2024, which was up 2,730.45% from $1.7 million recorded in FY2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' Change in Inventory peaked at $48.8 million during FY2024, and registered a low of -$15.3 million during FY2020.
  • In the last 3 years, Amphastar Pharmaceuticals' Change in Inventory had a median value of $11.7 million in 2022 and averaged $20.8 million.
  • In the last 5 years, Amphastar Pharmaceuticals' Change in Inventory crashed by 137.22% in 2020 and then surged by 2,730.45% in 2024.
  • Amphastar Pharmaceuticals' Change in Inventory (Yearly) stood at -$15.3 million in 2020, then soared by 91.78% to -$1.3 million in 2021, then soared by 1,033.70% to $11.7 million in 2022, then plummeted by 85.32% to $1.7 million in 2023, then spiked by 2,730.45% to $48.8 million in 2024.